Haig Bozigian is the chief development officer at Neurocrine Biosciences. Prior to joining Neurocrine, he was director of pharmaceutical development for ProCyte Corporation from 1993-1997, associate director of pharmacokinetics and metabolism at Sphinx Pharmaceuticals Corporation from 1990-1993 and clinical pharmacokineticist at Glaxo Inc from 1988-1990. He holds a Ph.D. in pharmaceutical sciences from the University of Arizona and a master's in pharmacodynamics and toxicology from the University of Nebraska Medical Center.